skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors

Abstract

Macrophage migration inhibitory factor (MIF) is a master regulator of proinflammatory cytokines and plays pathological roles when not properly regulated in rheumatoid arthritis, lupus, atherosclerosis, asthma and cancer. Unlike canonical cytokines, MIF has vestigial keto-enol tautomerase activity. Most of the current MIF inhibitors were screened for the inhibition of this enzymatic activity. However, only some of the enzymatic inhibitors inhibit receptor-mediated biological functions of MIF, such as cell recruitment, through an unknown molecular mechanism. The goal of this study was to understand the molecular basis underlying the pharmacological inhibition of biological functions of MIF. Here, we demonstrate how the structural changes caused upon inhibitor binding translate into the alteration of MIF-induced downstream signalling. Macrophage migration inhibitory factor activates phosphoinositide 3-kinases (PI3Ks) that play a pivotal role in immune cell recruitment in health and disease. There are several different PI3K isoforms, but little is known about how they respond to MIF. We demonstrate that MIF up-regulates the expression of Class IB PI3Ks in leucocytes. We also demonstrate that MIF tautomerase active site inhibitors down-regulate the expression of Class IB PI3Ks as well as leucocyte recruitment in vitro and in vivo. Finally, based on our MIF:inhibitor complex crystal structures, we hypothesize thatmore » the reduction in Class IB PI3K expression occurs because of the displacement of Pro1 towards the second loop of MIF upon inhibitor binding, which results in increased flexibility of the loop 2 and sub-optimal MIF binding to its receptors. These results will provide molecular insights for fine-tuning the biological functions of MIF.« less

Authors:
 [1];  [2];  [3];  [1];  [1]
  1. Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis MO USA
  2. Department of Pharmacology, Yale University School of Medicine, New Haven CT USA
  3. Institute of Biochemistry and Molecular Cell Biology, RWTH Aachen University, Aachen Germany
Publication Date:
Research Org.:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
OSTI Identifier:
1409606
Report Number(s):
BNL-114658-2017-JA¿¿¿
Journal ID: ISSN 1582-1838
DOE Contract Number:
SC0012704
Resource Type:
Journal Article
Resource Relation:
Journal Name: Journal of Cellular and Molecular Medicine; Journal Volume: 21; Journal Issue: 1
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Singh, Abhay Kumar, Pantouris, Georgios, Borosch, Sebastian, Rojanasthien, Siripong, and Cho, Thomas Yoonsang. Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors. United States: N. p., 2016. Web. doi:10.1111/jcmm.12949.
Singh, Abhay Kumar, Pantouris, Georgios, Borosch, Sebastian, Rojanasthien, Siripong, & Cho, Thomas Yoonsang. Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors. United States. doi:10.1111/jcmm.12949.
Singh, Abhay Kumar, Pantouris, Georgios, Borosch, Sebastian, Rojanasthien, Siripong, and Cho, Thomas Yoonsang. Tue . "Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors". United States. doi:10.1111/jcmm.12949.
@article{osti_1409606,
title = {Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors},
author = {Singh, Abhay Kumar and Pantouris, Georgios and Borosch, Sebastian and Rojanasthien, Siripong and Cho, Thomas Yoonsang},
abstractNote = {Macrophage migration inhibitory factor (MIF) is a master regulator of proinflammatory cytokines and plays pathological roles when not properly regulated in rheumatoid arthritis, lupus, atherosclerosis, asthma and cancer. Unlike canonical cytokines, MIF has vestigial keto-enol tautomerase activity. Most of the current MIF inhibitors were screened for the inhibition of this enzymatic activity. However, only some of the enzymatic inhibitors inhibit receptor-mediated biological functions of MIF, such as cell recruitment, through an unknown molecular mechanism. The goal of this study was to understand the molecular basis underlying the pharmacological inhibition of biological functions of MIF. Here, we demonstrate how the structural changes caused upon inhibitor binding translate into the alteration of MIF-induced downstream signalling. Macrophage migration inhibitory factor activates phosphoinositide 3-kinases (PI3Ks) that play a pivotal role in immune cell recruitment in health and disease. There are several different PI3K isoforms, but little is known about how they respond to MIF. We demonstrate that MIF up-regulates the expression of Class IB PI3Ks in leucocytes. We also demonstrate that MIF tautomerase active site inhibitors down-regulate the expression of Class IB PI3Ks as well as leucocyte recruitment in vitro and in vivo. Finally, based on our MIF:inhibitor complex crystal structures, we hypothesize that the reduction in Class IB PI3K expression occurs because of the displacement of Pro1 towards the second loop of MIF upon inhibitor binding, which results in increased flexibility of the loop 2 and sub-optimal MIF binding to its receptors. These results will provide molecular insights for fine-tuning the biological functions of MIF.},
doi = {10.1111/jcmm.12949},
journal = {Journal of Cellular and Molecular Medicine},
number = 1,
volume = 21,
place = {United States},
year = {Tue Sep 13 00:00:00 EDT 2016},
month = {Tue Sep 13 00:00:00 EDT 2016}
}